Amicus Therapeutics, Inc. (NASDAQ:FOLD), Coronado Biosciences Inc (NASDAQ:CNDO) and Receptos Inc (NASDAQ:RCPT) hit midday posting major gains this Monday. Getting a sluggish start to the week are Fate Therapeutics Inc (NASDAQ:FATE), Potash Corp. (NYSE:POT) and Chicago Bridge & Iron Company N.V. (NYSE:CBI).
Amicus, Receptos Keep on Climbing
This year has been a record-breaking year for initial public offerings with companies going public via SPAC mergers, direct listings and standard IPOS. At Techlive this week, Jack Cassel of Nasdaq and A.J. Murphy of Standard Industries joined Willem Marx of The Wall Street Journal and Barron's Group to talk about companies and trends in Read More
Amicus Therapeutics, Inc. (NASDAQ:FOLD) climbed +10.96% early in the day. The biopharmaceutical company has surged +36.2% over the past week, spurred by positive trial data and stock offer pricing. It’s been a breakout year for Amicus, which has gained +229.79% year-to-date.
Coronado Biosciences Inc (NASDAQ:CNDO) got a +9.05% jump today off of CB Pharma Acquisition’s filing for an IPO. Despite today’s gain, CNDO is still down -22.81% YTD.
Receptos Inc (NASDAQ:RCPT) rallied +8.94% early in the day after announcing the completion of a previously announced underwritten public offering. The biopharmaceutical company has climbed +348.6% in 2014, and its stock is approaching a new high. Thomas Steyer’s Farallon Capital holds 350,000 RCPT shares and profited significantly on the investment.
Chicago Bridge & Iron Company Tumbles on Rating Downgrade
The share price of Fate Therapeutics Inc (NASDAQ:FATE) dipped -6.38% today. The biotech company, another Farallon Capital pick, has declined -38.61% year-to-date.
Potash Corp. (NYSE:POT) fell -5.5% today. Last week, the stock surged on news that a flood at Russia’s Uralkali could make the company the world’s largest potash producer. The company has had a rather strong year, its price climbing +4.49% since January. Billionaire Richard Chilton has had a position in POT for several years.
Chicago Bridge & Iron Company N.V. (NYSE:CBI) tumbled -5.39% early in the day after being downgraded by Goldman Sachs to a sell rating. Warren Buffett picked up a stake in the energy infrastructure company at the start of 2013 and as of the end of Q3 2014 holds 10.7 million CBI shares. David Tepper has a 1.65-million-share position in the company as well.